These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17114339

  • 1. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
    Qin L, Zhao D, Liu X, Nagy JA, Hoang MV, Brown LF, Dvorak HF, Zeng H.
    Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339
    [Abstract] [Full Text] [Related]

  • 2. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells.
    Liu X, Zhao D, Qin L, Li J, Zeng H.
    J Biol Chem; 2008 Dec 05; 283(49):34159-67. PubMed ID: 18840614
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
    Yao YG, Duh EJ.
    Biochem Biophys Res Commun; 2004 Aug 27; 321(3):648-56. PubMed ID: 15358155
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.
    Hesser BA, Liang XH, Camenisch G, Yang S, Lewin DA, Scheller R, Ferrara N, Gerber HP.
    Blood; 2004 Jul 01; 104(1):149-58. PubMed ID: 15016650
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells.
    Chen C, Cui P, Zhao K, Niu G, Hou S, Zhao D, Zeng H.
    Microvasc Res; 2022 Mar 01; 140():104305. PubMed ID: 34958805
    [Abstract] [Full Text] [Related]

  • 10. Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin.
    Baggott RR, Alfranca A, López-Maderuelo D, Mohamed TM, Escolano A, Oller J, Ornes BC, Kurusamy S, Rowther FB, Brown JE, Oceandy D, Cartwright EJ, Wang W, Gómez-del Arco P, Martínez-Martínez S, Neyses L, Redondo JM, Armesilla AL.
    Arterioscler Thromb Vasc Biol; 2014 Oct 01; 34(10):2310-20. PubMed ID: 25147342
    [Abstract] [Full Text] [Related]

  • 11. Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.
    Xu Y, Yang B, Hu Y, Lu L, Lu X, Wang J, Shu Q, Cheng Q, Yu S, Xu F, Huang J, Liang X.
    Mol Neurobiol; 2017 Oct 01; 54(8):6556-6571. PubMed ID: 27734335
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nuclear factor of activated T cells and early growth response-1 cooperate to mediate tissue factor gene induction by vascular endothelial growth factor in endothelial cells.
    Schabbauer G, Schweighofer B, Mechtcheriakova D, Lucerna M, Binder BR, Hofer E.
    Thromb Haemost; 2007 Jun 01; 97(6):988-97. PubMed ID: 17549302
    [Abstract] [Full Text] [Related]

  • 14. Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling.
    Zheng JC, Chang KJ, Jin YX, Zhao XW, Li B, Yang MH.
    Med Sci Monit; 2019 Mar 26; 25():2228-2237. PubMed ID: 30913205
    [Abstract] [Full Text] [Related]

  • 15. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.
    Ryeom S, Baek KH, Rioth MJ, Lynch RC, Zaslavsky A, Birsner A, Yoon SS, McKeon F.
    Cancer Cell; 2008 May 26; 13(5):420-31. PubMed ID: 18455125
    [Abstract] [Full Text] [Related]

  • 16. Arsenic Trioxide Restrains Lung Cancer Growth and Metastasis by Blocking the Calcineurin-NFAT Pathway by Upregulating DSCR1.
    Yang MH, Wang YS, Shi XQ, Zhao XW, Li B.
    Curr Cancer Drug Targets; 2022 May 26; 22(10):854-864. PubMed ID: 35770414
    [Abstract] [Full Text] [Related]

  • 17. The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus.
    Siamakpour-Reihani S, Caster J, Bandhu Nepal D, Courtwright A, Hilliard E, Usary J, Ketelsen D, Darr D, Shen XJ, Patterson C, Klauber-Demore N.
    PLoS One; 2011 May 26; 6(6):e20412. PubMed ID: 21673995
    [Abstract] [Full Text] [Related]

  • 18. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H, Wang C, Jin G, Ruan H, Gu D, Wei L, Wang H, Wang N, Arunachalam E, Zhang Y, Deng X, Yang C, Xiong Y, Feng H, Yao M, Fang J, Gu J, Cong W, Qin W.
    Gastroenterology; 2017 Sep 26; 153(3):799-811.e33. PubMed ID: 28583823
    [Abstract] [Full Text] [Related]

  • 19. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
    Shin J, Lee JC, Baek KH.
    Cancer Lett; 2014 Jan 01; 342(1):70-81. PubMed ID: 24051307
    [Abstract] [Full Text] [Related]

  • 20. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.
    Chan B, Greenan G, McKeon F, Ellenberger T.
    Proc Natl Acad Sci U S A; 2005 Sep 13; 102(37):13075-80. PubMed ID: 16131541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.